ACTINIUM PHARMACEUTICALS, INC.

Profile

Company Names

ACTINIUM PHARMACEUTICALS, INC.

Addresses

501 FIFTH AVENUE, 3RD FLOOR, NEW YORK, NY 10017

391 LAFAYETTE STREET, NEWARK, NJ 07105

Phone Numbers

646-459-4201
(973) 344-6500

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$9,630,475.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2012-12-19 
$5,141,450.00 
$15,000,000.00 
$9,858,550.00 
Equity 
2
2011-10-31 
$364,000.00 
$750,000.00 
$386,000.00 
Debt 
1
2011-10-05 
$4,125,025.00 
$6,000,000.00 
$1,874,975.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DRAGAN 
 
CICIC 
EXECUTIVE OFFICER, DIRECTOR
ACTINIUM PHARMACEUTICALS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.
ENZA 
 
GUAGENTI 
EXECUTIVE OFFICER
ACTINIUM PHARMACEUTICALS, INC.
ROSEMARY 
 
MAZANET 
DIRECTOR
DIABETES AMERICA, INC.   |  CELLUMEN, INC.   |  CERNOSTICS PATHOLOGY, INC.   |  CERNOSTICS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  COLUMBIA CARE INC.   |  ONCOLYZE, INC.   |  CANNABIST CO HOLDINGS INC.   |  BIOCURIE, INC.
DAVID 
 
NICHOLSON 
DIRECTOR
ACTINIUM PHARMACEUTICALS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  LA MEND, INC.   |  BABOON MEGA CORP, INC.   |  VOLASTRA THERAPEUTICS, INC.   |  RAPALOGIX HEALTH, INC.
SANDESH 
 
SETH 
DIRECTOR
ACTINIUM PHARMACEUTICALS, INC.   |  RELMADA THERAPEUTICS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  CAMP NINE, INC.
RICHARD 
 
SHERMAN 
EXECUTIVE OFFICER, DIRECTOR
ACTINIUM PHARMACEUTICALS, INC.   |  FUNCTIONAL TECHNOLOGIES CORP   |  NUPULSE INC.   |  NUPULSECV, INC.
JACK 
V. 
TALLEY 
EXECUTIVE OFFICER, DIRECTOR
ACTINIUM PHARMACEUTICALS, INC.   |  CACTUS VENTURES, INC.
SERGIO 
 
TRAVERSA 
DIRECTOR
ARDANA HEALTHCARE FUND LP   |  RELMADA THERAPEUTICS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  ACTINIUM PHARMACEUTICALS, INC.   |  CAMP NINE, INC.   |  RELMADA THERAPEUTICS, INC.   |  ENZETA IMMUNOTHERAPIES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2012-12-31
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2012-12-19 
2011-11-03
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Debt 
2011-10-31 
2011-10-17
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Equity 
2011-10-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
119037
NONE
NONE
LAIDLAW + COMPANY (UK) LTD.
119037